ARUP Laboratories has launched the clinical CLARISPECT Multiple Myeloma MRD by Spectral Flow Cytometry assay for multiple ...
Hosted on MSN
Spectral AI Q1 earnings call highlights
Spectral AI (NASDAQ:MDAI) said it remains on track toward potential U.S. regulatory clearance and commercialization of its DeepView system for burn assessment, while reporting lower first-quarter ...
DALLAS, Feb. 28, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Spectral AI, Inc. (NASDAQ: MDAI), the reporting date of the financial results for the fourth ...
TORONTO, May 07, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, ...
DALLAS, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASD:MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...
FAYETTEVILLE, GA, UNITED STATES, July 20, 2026 /EINPresswire.com/ — Winter wheat spikes undergo substantial morphological and structural changes during grain filling, leading to corresponding ...
Spectral, an Israeli startup that’s developing automated tools to help developer teams spot mistakes such as confidential data buried in code, has emerged from stealth today with $6.2 million in a ...
SOMERVILLE, N.J., July 23, 2026 (GLOBE NEWSWIRE) -- Spectral Design & Test Inc. (SDT) an industry leader in custom circuit design of embedded SRAMs & design automation software announced its ...
The MarketWatch News Department was not involved in the creation of this content. DALLAS, March 10, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) ("Spectral AI" or the "Company"), an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results